Mediolanum Farmaceutici
company overview - Mediolanum Farmaceutici.
Employees
Milan Lombardy (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 201m | 63.1m | 63.8m | 73.0m | 49.7m | 49.7m |
| % growth | - | (69 %) | 1 % | 14 % | (32 %) | - |
| EBITDA | 28.0m | (5.0m) | (3.1m) | 3.6m | - | - |
| % EBITDA margin | 14 % | (8 %) | (5 %) | 5 % | - | - |
| Profit | 275m | (<1m) | (5.3m) | 1.9m | - | - |
| % profit margin | 137 % | (2 %) | (8 %) | 3 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| Total Funding | - | ||
Recent News about Mediolanum Farmaceutici
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Mediolanum Farmaceutici
Edit
ACQUISITION by Mediolanum Farmaceutici May 2020